← Evidence map

ArticleBioorganic & medicinal chemistry2026

Development of highly potent EP2 antagonists as novel anti-inflammatory neuroprotectants.

Chenyao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41932059